- pause slideshow
As pharmacy contractors in England suffer budget cuts and their leaders instigate legal action, Northern Ireland pharmacy contractor Terry Maguire argues why this might not be a good idea and what English contractors might learn from their Celtic cousins.
Evidence is emerging that biocides and heavy metals all contribute to the growing problem of antimicrobial resistance.
Previous court cases concerning informed consent of treatment have raised questions about what consent means in relation to pharmacists, medicines and prescribing.
William Seligman takes a look at what might happen to the US healthcare system and pharma under a Trump presidency.
The new urgent medicine supply scheme from NHS England requires more thought and revision.
Your RPS needs youSubscription
Show your passion and dedication to pharmacy by putting yourself forward for this year’s RPS national pharmacy board elections.
Recommendations made in Murray’s review for community pharmacy will not be simple to implementSubscription
Practical challenges, including building closer relationships with GPs, will need to be overcome if the recommendations in the Murray review on community pharmacy are to be implemented successfully.
We need fewer empty promises and more action and progress with rebalancing medicines legislation and pharmacy regulation — particularly around dispensing errors.
Cholesterol-lowering statin therapy for healthy people is not as simple as 'yes' or 'no'Subscription
Recent reports of large trials extolling the virtues of statins have led many to believe that low-risk patients should take them, but an examination of the evidence provides food for thought.
There are a number of factors that contribute to patients’ fear and reluctance to take osteoporosis drugs, leaving them at increased risk of fractures.
Research suggests no substantive outcome differences between the use of originator biologics and their biosimilar counterparts Source: Shutterstock.com
Caution is required when prescribing or dispensing long-acting beta agonists to manage airways diseases, such as asthma.
Shanelle Hall from UNICEF discusses the breakthrough pentavalent vaccine three-year tender with six vaccine suppliers.
The author of the 2013 report which looked at patient safety in the NHS after the Mid Staffordshire Hospital scandal speaks to Jenny Bryan to share his thoughts on whether progress has been made.
Six candidates in the race to be director-general of the World Health Organization outline their priorities and vision for global health.
Maree Todd, pharmacist and member of the Scottish Parliament, speaks to Jenny Bryan about the successes of community pharmacy in Scotland, what can England learn from them and her life in politics so far.
Learn about high-intensity interval trainingSubscription
The one minute workout, by Martin Gibala
Introduction to drug disposition and pharmacokinetics, by Stephen H Curry and Robin Whelpton
Life histories of genetic disease: patterns and prevention in postwar medical genetics by Andrew J Hogan
A taste of his own medicine, by Linda Fawke
The Royal Pharmaceutical Society (RPS) Welsh Pharmacy Board launched its manifesto in November 2015. Mair Davies, director for RPS Wales, talks to Julia Robinson about progress made since the launch, and her objectives for 2017 and beyond.
New RPS director for England, Robbie Turner, tells Julia Robinson about his plans for 2017 and how he hopes his experience as chief executive of Community Pharmacy West Yorkshire will help him achieve his goals.
Alex MacKinnon, director for the Scotland at the Royal Pharmaceutical Society (RPS), tells Julia Robinson what 2017 will mean for pharmacists in Scotland and how RPS Scotland plans to embrace new opportunities on behalf of the profession.
After seven years in the pharmacy world, Helen Gordon is departing as chief executive of the Royal Pharmaceutical Society to enter pastures new at the Royal Society of Medicine. Here, she talks to Julia Robinson about her proudest moments and what advice she would give to her successor.
The story of William Wake’s career is heart warming (The Pharmaceutical Journal 2017;298:111), but contains a detail that reveals the failure of leadership in pharmacy.
I am surprised Terry Maguire says in his letter that community pharmacists should avoid the medicalisation of life when we are already treating other diseases that are also prevalent with increasing age, such as diabetes, hypertension, heart disease, cancer, arthritis and dementia (The Pharmaceutical Journal 2017;298:100).
A quick intervention recommendation by community pharmacists for patients using inhalersSubscription
Many pharmacists are probably busy reviewing inhaler use and technique as part of their medicines use reviews and new medicine service processes for patients with asthma and chronic obstructive pulmonary disease (COPD).
For the seventh year running, the National Paediatric Diabetes Audit (NPDA) shows children living with diabetes are being helped to manage their blood glucose levels (HbA1c) and so reduce the risk of developing ...
We are calling for article submissions that highlight best practice in relation to the management of long-term conditions.
Baguiasri Mandane shares her experience and what she learnt on her oncology rotation at University Hospitals of Leicester NHS Trust
2017 could see a rise in patient-centred technologies across pharmacy. Martin Hao, managing director at Healthera, a new medicines management app, looks at the reasons behind the trend.
Additional funding for R&D post-Brexit is a welcome move from the UK government, but there are other related issues to consider as well.
Thomas Geoffrey Booth (1928-2016)Subscription
Thomas Geoffrey Booth, past president of the Royal Pharmaceutical Society, founded the UK’s first department of pharmacy practice.
Frank P Palopoli (1922–2016) Subscription
The scientist who discovered the fertility drug clomifene was known as a modest man who mentored his staff.
Kirit Patel (1949-2016)Subscription
A self-made man who started out wanting to own a shop to support his family, Kirit Patel’s lifetime achievements are inspirational.
Philip Majerus (1936-2016)Subscription
Majerus was one of the first researchers who discovered the benefits of low dose aspirin in preventing heart attacks and strokes.